KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others. The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People’s Republic of China.
Metrics to compare | 600422 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600422PeersSector | |
---|---|---|---|---|
P/E Ratio | 18.2x | 26.8x | −0.5x | |
PEG Ratio | 1.28 | −0.17 | 0.00 | |
Price/Book | 2.1x | 2.4x | 2.6x | |
Price / LTM Sales | 1.4x | 3.1x | 3.3x | |
Upside (Analyst Target) | 46.5% | 10.6% | 43.3% | |
Fair Value Upside | Unlock | −5.8% | 6.9% | Unlock |